October 17-20, 2022
Boston, MA
The industry’s preeminent event on novel drug targets and technologies will highlight advances in current and emerging targets and technologies in drug discovery and development.
Meet YUMAB’s David Passmore (Business Development) in Boston to learn more about our fully human antibody technology platform, its potential in drug discovery and development, and the company’s diverse business opportunities.
People attending from YUMAB:
David Passmore, PhD
Business Development
YUMAB GmbH
Science Campus Braunschweig-Süd
Inhoffenstr. 7
38124 Braunschweig – Germany
Phone: +49 531 481170-0
Fax: +49-531 481170-17
